Diet, physical exercise and Orlistat administration increase serum Anti-Mullerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)

被引:34
作者
Vosnakis, Christos [1 ]
Georgopoulos, Neoklis A. [2 ]
Rousso, David [1 ]
Mavromatidis, Georgios [1 ]
Katsikis, Ilias [3 ]
Roupas, Nikolaos D. [2 ]
Mamali, Irene [2 ]
Panidis, Dimitrios [3 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 3, GR-54006 Thessaloniki, Greece
[2] Univ Patras, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol, Patras 26500, Greece
[3] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 2, Div Endocrinol & Human Reprod, GR-54006 Thessaloniki, Greece
关键词
Anti-Mullerian Hormone; LH; insulin resistance; Orlistat; PCOS; INHIBITING SUBSTANCE LEVELS; LUTEINIZING-HORMONE; INSULIN-RESISTANCE; MOUSE OVARY; LEAN WOMEN; OBESITY; GROWTH; ASSOCIATION; GHRELIN; FSH;
D O I
10.3109/09513590.2012.736557
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study investigates the combined effect of diet, physical exercise and Orlistat for 24 weeks, on serum Anti-Mullerian Hormone (AMH) levels in overweight and obese women with polycystic ovary syndrome (PCOS) and in overweight and obese controls. Sixty-one (61) selected women with PCOS and 20 overweight and obese controls followed an energy-restricted diet, physical exercise plus Orlistat administration (120 mg, 3 times per day) for 24 weeks. At baseline, week 12 and week 24, serum levels of AMH, FSH, LH, PRL, androgens, sex hormone-binding globulin (SHBG), glucose, and insulin were measured and Free Androgen Index (FAI) and Insulin Resistance (IR) indices were calculated. In PCOS women, serum AMH levels increased after 12 and 24 weeks of treatment. After 12 weeks LH and SHBG were increased, while Testosterone decreased. After 12 and 24 weeks, FAI was decreased and all indices of IR were significantly improved. We concluded that in overweight and obese women with PCOS Orlistat administration, combined with diet and physical exercise, for 24 weeks, resulted in significant weight loss, improvement of hyperandrogenism and insulin sensitivity, and increased serum AMH levels.
引用
收藏
页码:242 / 245
页数:4
相关论文
共 50 条
[41]   Health Behavior Associated with Anti-Mullerian Hormone (AMH) Relationship in Women with Polycystic Ovary (PCO) Syndrome [J].
Atlihan, Ufuk ;
Derundere, Umit .
AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2023, 47 (05) :1015-1022
[42]   Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women [J].
Yue, Chao-Yan ;
Lu, Lou-kai-yi ;
Li, Meng ;
Zhang, Qian-Lan ;
Ying, Chun-Mei .
PLOS ONE, 2018, 13 (08)
[43]   Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome [J].
Somunkiran, Asli ;
Yavuz, Tevfik ;
Yucel, Oguz ;
Ozdemir, Ismail .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2007, 134 (02) :196-201
[44]   Anti-Mullerian hormone and fertility disturbances in obese women and women with polycystic ovary syndrome [J].
Wikarek, Tomasz ;
Olszanecka-Glinianowicz, Magdalena ;
Chudek, Jerzy ;
Sikora, Jerzy ;
Skalba, Piotr .
GINEKOLOGIA POLSKA, 2011, 82 (03) :205-209
[45]   Serum anti-Mullerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age [J].
Butt, Muhammad Salman ;
Saleem, Javeria ;
Aiman, Sobia ;
Zakar, Rubeena ;
Sadique, Iftikhar ;
Fischer, Florian .
BMC WOMENS HEALTH, 2022, 22 (01)
[46]   Comparison of two different anti-mullerian hormone measurement methods and evaluation of anti-mullerian hormone in polycystic ovary syndrome [J].
Gok, Gamze ;
Bal, Ceylan ;
Secen, Elcin Islek ;
Desdicioglu, Raziye ;
Akbiyik, Filiz ;
Yilmaz, Gulsen .
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2025, 50 (03) :357-363
[47]   Anti-Mullerian Hormone: A Molecular Key to Unlocking Polycystic Ovary Syndrome? [J].
Abbott, David H. ;
Hutcherson, Beverly A. ;
Dumesic, Daniel A. .
SEMINARS IN REPRODUCTIVE MEDICINE, 2024, 42 (01) :41-48
[48]   Anti-Mullerian hormone reflects the severity of polycystic ovary syndrome [J].
Jacob, S. L. ;
Field, H. P. ;
Calder, N. ;
Picton, H. M. ;
Balen, A. H. ;
Barth, J. H. .
CLINICAL ENDOCRINOLOGY, 2017, 86 (03) :395-400
[49]   Anti-Mullerian hormone measurement for the diagnosis of polycystic ovary syndrome [J].
Sathyapalan, Thozhukat ;
Al-Qaissi, Ahmed ;
Kilpatrick, Eric S. ;
Dargham, Soha R. ;
Atkin, Stephen L. .
CLINICAL ENDOCRINOLOGY, 2018, 88 (02) :258-262
[50]   Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study [J].
Bhide, Priya ;
Kulkarni, Abhijit ;
Dilgil, Merve ;
Dhir, Puja ;
Shah, Amit ;
Gudi, Anil ;
Homburg, Roy .
GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (10) :801-806